我们应用 MEA方案联合应用耐药逆转剂 Cs A治疗急性难治性髓性白血病 16例 ,取得了较好的疗效。 CR后第 1年每 2月～ 3月强化 1次 ,第 2年第 3个月～ 4个月强化 1次 ,可明显减少复发率 ,现报道总结分析如下。1　资料与方法1.1　一般资料1.1.1　观察对象 :16例均为我院 1998年 6 We use the MEA regimen combination of drug resistance reversal agent Cs A treatment of acute refractory myelogenous leukemia in 16 cases, and achieved good results. In the first year after CR, there is an increase in every two months to three months and in one month from the third month to the fourth month of the second year, which can significantly reduce the recurrence rate. The report is summarized as follows. 1 Materials and Methods 1.1 General Information 1.1.1 Observed: 16 cases were in our hospital in 1998 6